Chemistry:Gadobenic acid

From HandWiki
Revision as of 03:35, 11 June 2022 by imported>NBrush (simplify)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Complex of gadolinium by a chelating agent derived from DTPA
Gadobenic acid
Structure of Gadobenic acid.png
Clinical data
Trade namesMultihance
Other namesgadobenate dimeglumine (USAN US)
AHFS/Drugs.comProfessional Drug Facts
ATC code
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
Chemical and physical data
FormulaC22H28GdN3O11
Molar mass667.73 g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Gadobenic acid (INN, brand name Multihance) is a complex of gadolinium with the ligand BOPTA. In the form of the methylglucamine salt meglumine gadobenate (INNm) or gadobenate dimeglumine (USAN), it is used as a gadolinium-based MRI contrast medium.[3]

BOPTA is a derivative of DTPA in which one terminal carboxyl group, –C(O)OH is replaced by -C–O–CH2C6H5. Thus gadobenic acid is closely related to gadopentetic acid. BOPTA itself was first synthesized in 1995.[4] In the "gadobenate" ion gadolinium ion is 9-coordinate with BOPTA acting as an 8-coordinating ligand. The ninth position is occupied by a water molecule, which exchanges rapidly with water molecules in the immediate vicinity of the strongly paramagnetic complex, providing a mechanism for MRI contrast enhancement. 139La NMR studies on the diamagnetic La-BOPTA2− complex suggest that the Gd complex maintains in solution the same kind of coordination as found, by X-ray crystallography, in the solid state for Gd-BOPTA disodium salt.[4]

References

  1. "Multihance, 0.5 M solution for injection - Summary of Product Characteristics (SmPC)". 14 August 2019. https://www.medicines.org.uk/emc/product/1388/smpc. 
  2. "Multihance- gadobenate dimeglumine injection, solution". https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59077a3e-5f03-4342-ae24-856267545631. 
  3. Sweetman, Sean C., ed (2009). "Contrast Media". Martindale: The Complete Drug Reference (36th ed.). London: Pharmaceutical Press. pp. 1478. ISBN 978-0-85369-840-1. 
  4. 4.0 4.1 "Novel Contrast Agents for Magnetic Resonance Imaging. Synthesis and Characterization of the Ligand BOPTA and Its Ln(III) Complexes (Ln = Gd, La, Lu). X-ray Structure of Disodium (TPS-9-145337286-C-S)-[4-Carboxy-5,8,11-tris(carboxymethyl)-1-phenyl-2-oxa- 5,8,11-triazatridecan-13-oato(5-)]gadolinate(2-) in a Mixture with Its Enantiomer". Inorganic Chemistry 34 (3): 633–643. 1995. doi:10.1021/ic00107a017. ISSN 0020-1669. 

External links